Atlas Trials

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants

Clinical trial NCT07011511 · RECRUITING

Trial details

NCT number
NCT07011511
Sponsor
Medicines for Malaria Venture
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria, Falciparum
Start date
2025-06-30
Primary completion
2027-12-02
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.